10 Year Experience with the Malaysian ACS & PCI Registries:

Slides:



Advertisements
Similar presentations
ACTION Registry (Acute Coronary Treatment and Intervention Outcomes Network) Initial Report 1st Quarter 2007 Results Report prepared by: www. ncdr.com.
Advertisements

Unstable angina and NSTEMI
Inequalities across Europe in access to primary angioplasty to treat acute heart attack patients -the cross-border dimension- John Martin, MD, FRCP, FESC,
National Cardiovascular Disease Database (NCVD) NCVD Acute Coronary Syndrome (ACS) Registry An Update Dato’ Dr Azhari Rosman Chairman of NCVD ACS Registry.
NCVD-ACS REGISTRY. Annual Report of the Acute Coronary Syndrome (ACS) Registry, Malaysia 2006 NCVD-ACS Registry: Annual Report 2006 Published by: Clinical.
Overview of NCVD Data Usage Prof. Dr. Wan Azman Wan Ahmad Chair of NCVD Writing Committee.
Canadian Diabetes Association Clinical Practice Guidelines Acute Coronary Syndromes and Diabetes Chapter 26 Jean-Claude Tardif, Phillipe L. L’Allier, David.
K Fox, W Remme, C Daly, M Bertrand, R Ferrari, M Simoons On behalf of the EUROPA investigators. The diabetic sub study of.
National Cardiovascular Disease Database (NCVD) 2009 Update NHAM ASM April 2009 National Cardiovascular Disease Database (NCVD) ACS Registry PCI.
Cardiovascular Care in Malaysia: Role of NCVD
National Cardiovascular Disease Database Percutaneous Coronary Intervention (PCI) Registry Malaysia NCVD-PCI Registry – Are We Any Different? Presented.
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Anterior Depressions Angiographic and Clinical Outcomes Among Patients with Acute Coronary Syndromes Presenting with Anterior ST-Segment Depressions C.
NCVD Percutaneous Coronary Intervention (PCI) Registry An update Dato Dr Rosli Mohd Ali Chairman of NCVD PCI Registry Hilton Kuala Lumpur 17 th April 2009.
1 What is… ? Disparities Among Women in Acute Cardiac Care Frances Canet, MD Cath Conference Thursday, May 26, 2011.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Clinical implications. Burden of coronary disease 56 millions deaths worldwide in millions deaths worldwide in % due to CV disease (~ 16.
Around-the-Clock Primary Angioplasty: A Process of Care Analysis Comparing Off-Hours and Normal Hours Treatment of Acute STEMI R Leung, D Lundberg, D Galbraith,
CPORT- E Trial Randomized trial comparing outcomes of non-primary PCI at hospitals with and without on-site cardiac surgery.
Clopidogrel Audit Vikas Jasoria December What is it? Clopidogrel is a thienopyridine antiplatelet drug which reduces platelet aggregation by inhibiting.
Aim To determine the effects of a Coversyl- based blood pressure lowering regimen on the risk of recurrent stroke among patients with a history of stroke.
Naotsugu Oyama, MD, PhD, MBA A Trial of PLATelet inhibition and Patient Outcomes.
Baseline characteristics. Patient flow Completed Completed Perindopril Placebo Randomised Not randomised Registered.
Cardioprotective Effects of Postconditioning in Patients Treated with Primary PCI Evaluated with Magnetic Resonance Jacob T Lønborg Niels Vejlstrup, Erik.
Prof. Dr. Sigmund Silber, FESC, FACC On behalf of the RESOLUTE
2016 Annual Data Report, Vol 2, ESRD, Ch 5
Associate Professor, Honorary Consultant Cardiologist
CARDIOVASCULAR DISEASE IN WOMEN :
A Clinical profile of patients enrolled in the Pakistan ACS registry
Risk Stratification of Chest Pain: Best Practices
Arch Intern Med. 2007;167(1): doi: /archinte Figure Legend:
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
WHO Collaborating Centre in Calgary, Canada
Summary of the Annual Report of the NCVD-ACS Registry
Eva Kline-Rogers RN, NP, AACC University of Michigan
 Gender based differences in the presentation, treatment and outcome of Acute Coronary Syndrome patients : insights from the Himachal Pradesh ACS-registry.
Improved Outcomes in Patients with Non-ST-Elevation Myocardial Infarction during 20 Years are Related to Implementation of Evidence-based Treatments –
Is There a Role for Aspiration in STEMI?
Copyright © 2009 American Medical Association. All rights reserved.
On behalf of J. Belardi, M. Leon, L. Mauri,
Has acute myocardial infarction mortality hit rock bottom
Diabetes in Suriname II PAHO-DOTA Workshop on Quality of Diabetes Care
Systolic Blood Pressure Intervention Trial (SPRINT)
Coronary Catheterization and Percutaneous Coronary Intervention in China 10-Year Results From the China PEACE-Retrospective CathPCI Study Xin Zheng,
NCVD Acute Coronary Syndrome (ACS) Registry An Update Dato’ Dr Azhari Rosman Chairman of NCVD ACS Registry Sentral Accord Room, Hilton Kuala Lumpur 19th.
Section A: Introduction
European Heart Association Journal 2007 April
Monthly Journal article review: Vimmi Kang PGY 2
Overview of NCVD Data Usage
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Dr. PJ Devereaux on behalf of POISE Investigators
Global Registry of Acute Coronary Events: GRACE
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
What oral antiplatelet therapy would you choose?
How to Optimize Cholesterol Management in High-Risk CV Patients
ACC/SCAI – i2 Summit Late Breaking Clinical Trials March 29, 2008
Elevated Admission Plasma Glucose Following ACS
NCVD-ACS REGISTRY.
ARISE Trial Aggressive Reduction of Inflammation Stops Events
China PEACE risk estimation tool for in-hospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic.
Train-the-Trainer Cases
Urban–Rural Comparisons in Hospital Admission, Treatments, and Outcomes for ST-Segment–Elevation Myocardial Infarction in China From 2001 to 2011 A Retrospective.
Atlantic Cardiovascular Patient Outcomes Research Team
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective.
Train-the-Trainer Cases
Train-the-Trainer Cases
MRRs and EMRRs for women with ACS
Cardiovascular Epidemiology and Epidemiological Modelling
Proposed future revascularisation strategy in patients with ESRD based on our current results and previous guideline recommendations. Proposed future revascularisation.
Presentation transcript:

10 Year Experience with the Malaysian ACS & PCI Registries: Joint Meeting of Coronary Revascularisation (JCR), Busan. 9-10 December 2016. Session 5: 1550hrs, Room A 10 Year Experience with the Malaysian ACS & PCI Registries: translation into research and practice Dr Alan Fong MBChB(Bristol), MRCP(UK), FRCP (Edin), FACC, FESC, FAPSIC, FNHAM, FAsCC Consultant Cardiologist, Sarawak General Hospital Heart Centre; & Head, Clinical Research Centre, Sarawak General Hospital Adjunct Professor, Swinburne University of Technology

National Health and Morbidity Surveys.. (e.1986) NHMS 2015: of adults over 18, 17.5% have DM; 30.3% have hypertension; 47.7% have hypercholesterolaemia; 17.7% are obese, 22.8% smokers.

The NCVD Registries (e.2006) http://www.acrm.org.my/ncvd/aboutUs_overview.php

NCVD PCI Registry Report 2013-2014

Snapshot from the Annual Report of the NCVD-ACS Registry 2011-2013 Suggested citation: W.A. Wan Azman, K.H. Sim. (Eds). Annual Report of the NCVD-ACS Registry, Year 2011-2013. Kuala Lumpur, Malaysia: National Cardiovascular Disease Database, 2015.

NCVD-ACS Registry Participating Hospitals HTF HQEI HQEII HRPZ II HSB HPP HSNZ HRPB HTAA PJHUS UMMC IJN HKL HTAR HS HA Total SDP= 19 hospitals HTJ HSA *Each SDP started to contribute data at different time period HM NCVD-ACS Registry, Malaysia (2011-2013)

N ACS admissions = 14,763

Mean age: 58.5 (12.2) years N ACS admissions = 14,763

N ACS admissions = 14,763

Hypertension 65% Diabetes 46% CV Risk factors 2006-2010 (N=16,866) 2011 (N=4,047) 2012 (N=4,589) 2013 (N=6,127) 2011-2013 (N=14,763) Dyslipidaemia 33.0 39.2 36.4 37.0 37.4 Hypertension 61.0 67.0 65.6 63.2 65.0 Diabetes 43.0 46.2 46.6 45.0 45.8 Family History of premature CVD 11.0 14.5 13.2 12.4 MI history 19.0 22.0 20.8 16.2 19.2 Documented CAD 17.0 17.3 20.2 24.4 21.2 New onset angina (< 2 weeks) 55.0 61.4 57.6 56.4 58.2 Chronic angina (onset > 2 weeks ago) 11.4 9.6 9.4 9.9 Chronic Lung Disease 4.0 3.6 2.8 3.1 3.2 Renal disease 7.0 8.2 7.2 7.8 Peripheral vascular disease 1.0 1.2 0.8 0.6 Cerebrovascular disease 4.2 3.5 3.8 Heart Failure 8.6 5.3 Current Smoker 37.6 37.8 38.2 38.0 BMI > 23kgm-2 75.0 75.6 78.2 76.5 Hypertension 65% Diabetes 46%

Presence of cumulative risk factors (Percentage), NCVD-ACS Registry, 2011-2013

Type of cardiac presentation for patients with ACS (%) by admission, NCVD-ACS Registry, 2006 - 2013 2007 2008 2009 2010 2011 2012 2013 N 3,392 3,640 2,839 3,594 3,401 4,047 4,589 6,127 STEMI 42.0 46.0 54.0 47.0 53.0 50.8 52.0 50.0 NSTEMI 34.0 29.0 24.0 30.0 27.0 25.0 26.2 UA 22.0 17.0 22.2 23.3 23.8

Age group of patients by ACS stratum NCVD-ACS Registry, 2011-2013 NSTEMI

Type of treatment among STEMI patients by Age Group , NCVD-ACS Registry, 2011-2013

NCVD ACS In-Hospital Mortality and 30-day Follow up: 2006-2010 VS 2011-2013 Outcome at discharge 30-day FU Year Outcome N % 2006-2010 Alive 15531 92 14429 86 Died 1335 8 2437 14 2011 3729 92.2 3681 91.0 318 7.8 366 9.0 2012 4234 4173 355 416 2013 5670 92.6 5586 91.2 457 7.4 541 8.8 2011-2013 13633 92.4 13440 1130 7.6 1323 Outcome at discharge is similar but 30 day outcomes improved significantly

30-day outcome is better at cardiologist centre Outcome at discharge 30-day FU Physician Centre Cardiologist Centre Year Outcome N % 2006-2010 Alive 5163 92 10368 4905 87 9524 85 Died 454 8 881 712 13 1725 15 2011 2839 92.2 890 92.0 2801 91.0 880 241 7.8 77 8.0 279 9.0 2012 3368 866 92.6 3315 90.8 858 91.8 286 69 7.4 339 9.2 8.2 2013 5031 639 92.8 4948 638 407 50 7.2 490 51 2011-2013 11238 92.4 2395 11064 2376 934 7.6 196 1108 215 30-day outcome is better at cardiologist centre

STEMI: comparison between NCVD and TIMI developmental dataset An Asian Validation of the TIMI risk score for ST-Segment Elevation Myocardial Infarction: Results and Implications for Cardiac Care in a Developing Country. Sharmini Selvarajah, Alan Fong Yean Yip, Gunavathy Selvaraj, Jamaiyah Haniff, Cuno S.P.M. Uiterwaal, Michiel L. Bots, PLoS One 2012;7(7):e40249

STEMI reperfusion strategies in UK and Malaysia approx. 70% lytic, approx 9% PPCI NCVD 2013 – approx. 70% lytic, 9% with PPCI for STEMI

The NCVD PCI Registry…

SDPs for the NCVD PCI Registry

Baseline Characteristics

Cardiovascular Risk Factors

Coronary stent implants!

Clinical outcomes

Primary PCI in STEMI – with vs without transfer

MySTEMI Network (Klang Valley)

... Addressing the problems >3 billion at risk

A recent hit…. with global implications

Regional collaboration – 2016 and beyond

ACS – a patient from Marudi (~130km from Miri by road) Melaka to Serdang (2 hours)

Summary: how the NCVD has helped us…. Systematic collection of local data important Better understanding of the local disease burden Strategies to improve therapeutic protocols Addressing the evidence gap by research Translating research into guidelines

Sarawak General Hospital